Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.48)
# 1,058
Out of 4,457 analysts
582
Total ratings
46.4%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintained: Buy | n/a | $24.12 | - | 32 | Jun 28, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $30 | $18.00 | +66.67% | 17 | Jun 23, 2026 | |
| INCY Incyte | Maintained: Buy | $123 | $114.66 | +7.27% | 39 | Jun 15, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $46 | $21.78 | +111.20% | 7 | Jun 15, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $34 | $23.85 | +42.56% | 29 | Jun 15, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $111 | $74.50 | +48.99% | 10 | Jun 3, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $6 | $2.16 | +177.78% | 13 | Jun 1, 2026 | |
| CELC Celcuity | Rated: Buy | $150 → $175 | $102.52 | +70.70% | 9 | May 15, 2026 | |
| MGNX MacroGenics | Maintained: Hold | $4 | $4.86 | -17.70% | 34 | May 14, 2026 | |
| NKTX Nkarta | Maintained: Buy | $11 | $2.85 | +285.96% | 25 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $8 | $8.12 | -1.48% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $29.34 | +56.78% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $208 → $200 | $104.74 | +90.95% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $54.28 | -13.41% | 54 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $15.33 | +147.96% | 4 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.86 | +179.72% | 5 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $18.60 | +115.05% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $5.66 | +200.35% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.57 | +250.19% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $4.23 | +77.30% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.48 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $3.91 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.30 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $30.43 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.16 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $0.9094 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $8.56 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.9437 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $1.12 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $2.26 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.64 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $60.13 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 | $4.16 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $293.52 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $57.67 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $80.69 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $23.14 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.0001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $10.71 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.91 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $9.64 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $237.72 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.23 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.68 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $39.04 | n/a | 2 | Apr 8, 2013 |
Zymeworks
Jun 28, 2026
Maintained: Buy
Price Target: n/a
Current: $24.12
Upside: -
Crescent Biopharma
Jun 23, 2026
Maintained: Buy
Price Target: $30
Current: $18.00
Upside: +66.67%
Incyte
Jun 15, 2026
Maintained: Buy
Price Target: $123
Current: $114.66
Upside: +7.27%
Syndax Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $46
Current: $21.78
Upside: +111.20%
Nurix Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $34
Current: $23.85
Upside: +42.56%
Disc Medicine
Jun 3, 2026
Maintained: Buy
Price Target: $111
Current: $74.50
Upside: +48.99%
Compass Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $6
Current: $2.16
Upside: +177.78%
Celcuity
May 15, 2026
Rated: Buy
Price Target: $150 → $175
Current: $102.52
Upside: +70.70%
MacroGenics
May 14, 2026
Maintained: Hold
Price Target: $4
Current: $4.86
Upside: -17.70%
Nkarta
May 13, 2026
Maintained: Buy
Price Target: $11
Current: $2.85
Upside: +285.96%
May 12, 2026
Rated: Buy
Price Target: $7 → $8
Current: $8.12
Upside: -1.48%
May 12, 2026
Maintained: Buy
Price Target: $48 → $46
Current: $29.34
Upside: +56.78%
May 8, 2026
Maintained: Buy
Price Target: $208 → $200
Current: $104.74
Upside: +90.95%
May 6, 2026
Rated: Hold
Price Target: $47
Current: $54.28
Upside: -13.41%
Apr 28, 2026
Maintained: Buy
Price Target: $38
Current: $15.33
Upside: +147.96%
Apr 22, 2026
Maintained: Buy
Price Target: $8
Current: $2.86
Upside: +179.72%
Apr 8, 2026
Maintained: Buy
Price Target: $40
Current: $18.60
Upside: +115.05%
Mar 18, 2026
Maintained: Buy
Price Target: $17
Current: $5.66
Upside: +200.35%
Mar 5, 2026
Reiterated: Buy
Price Target: $9
Current: $2.57
Upside: +250.19%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $4.23
Upside: +77.30%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.48
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $3.91
Upside: n/a
Mar 12, 2025
Maintained: Buy
Price Target: $4
Current: $1.30
Upside: n/a
Nov 15, 2024
Maintained: Buy
Price Target: $4
Current: $30.43
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $4
Current: $2.16
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $7 → $6
Current: $0.9094
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $8.56
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.9437
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $3 → $1
Current: $1.12
Upside: n/a
Mar 12, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $2.26
Upside: n/a
Mar 11, 2021
Maintained: Hold
Price Target: $6
Current: $2.64
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $18 → $21
Current: $60.13
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $160
Current: $4.16
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $293.52
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $57.67
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $80.69
Upside: n/a
Apr 27, 2018
Maintained: Hold
Price Target: $17 → $16
Current: $23.14
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.0001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $10.71
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.91
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $9.64
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $237.72
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $6.23
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.68
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $39.04
Upside: n/a